For GLP-1 patients, the most relevant actives are: PDRN (polydeoxyribonucleotide)
While specific details about expanded coverage and access are still forthcoming, employers should stay informed as updates become available
At Glow Lab, we use these medications as part of a guided planhelping you understand how your body is responding and adjusting along the way
Semaglutide works by slowing gastric emptying , meaning food stays in the stomach longer, and by signaling fullness to the brain, which reduces appetite
coverage through an employer) insurance may be able to pay as little as $25 for a one-, two-, or three-month prescription
Have a subject youd like us to cover in a future article